Pia Burman

Medicine & Life Sciences

1. Pituitary Neoplasms 100%
2. Pituitary ACTH Hypersecretion 62%
3. Acromegaly 59%
4. Growth Hormone 59%
5. Hydrocortisone 36%
6. Temozolomide 34%
7. Adrenal Insufficiency 29%
8. Insulin-Like Growth Factor I 27%
9. pegvisomant 25%
10. Corticotrophs 24%
11. Therapeutics 23%
12. Prolactinoma 23%
13. Endocrinology 22%
14. Hypopituitarism 20%
15. Radiotherapy 19%
16. Somatostatin 19%
17. Body Composition 19%
18. Hormone Replacement Therapy 18%
19. Neoplasms 18%
20. Cabergoline 17%
21. Meta-Analysis 17%
22. Sweden 15%
23. Safety 15%
24. Placebos 15%
25. Addison Disease 15%
26. Mortality 15%
27. metomidate 15%
28. Brain Neoplasms 14%
29. Adrenal Rest Tumor 14%
30. aryl hydrocarbon receptor-interacting protein 13%
31. ATR-X syndrome 13%
32. somatostatin receptor 5 13%
33. Nelson Syndrome 12%
34. Quality of Life 12%
35. Cushing Syndrome 12%
36. Incidence 12%
37. Systematic Reviews 11%
38. Cross-Over Studies 11%
39. Craniopharyngioma 11%
40. Morbidity 11%
41. Mutation 11%
42. Cyclin-Dependent Kinase Inhibitor p27 11%
43. Adrenalectomy 11%
44. Fat Necrosis 11%
45. Multiple Endocrine Neoplasia 10%
46. Congenital Adrenal Hyperplasia 10%
47. Hereditary Nonpolyposis Colorectal Neoplasms 10%
48. Cortisone 10%
49. Langerhans Cell Histiocytosis 10%
50. Dopamine Agonists 10%